Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial70

File Visits

Downloads
36218-371.pdf29

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial49

Number of downloads in the range

Downloads
36218-371.pdf7

Views

Views
February 20253
March 202518
April 202510
May 20250
June 20250
July 202517
August 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • February 2025
    0
  • March 2025
    0
  • April 2025
    2
  • May 2025
    3
  • June 2025
    0
  • July 2025
    1
  • August 2025
    1
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
United States11
Hong Kong10
Brazil7
Barbados1
Ireland1
Mexico1
 

Top countries by downloads

Downloads
United States2
Hong Kong2
 

Top cities views

Views
Hong Kong10
Bridgetown1
Campinas1
Campo Largo1
Dublin1
Meriden1
Pekin1
Providence1
Recife1
Rio Claro1
 

Top cities by downloads

Downloads
Hong Kong2